Multiparametric Home Telemonitoring of Patients With Chronic Obstructive Pulmonary Disease Exacerbation

Recruiting N/A Interventional Study
COPD COPD Exacerbation Acute
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
60 (estimated)
Sponsor
University of Trieste · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Chronic obstructive pulmonary disease (COPD) exacerbations are risk factors for disease progression and short-term re- hospitalizations. We propose a randomized controlled trial to evaluate the efficacy of a one-device multiparameter telemonitoring in reducing functional decline, symptoms, and risk of re-hospitalization of patients discharged after hospitalization for exacerbated COPD.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Able to understand and sign the informed consent form. 2. Already established diagnosis of COPD according to Global Initiative for Obstructive Lung Disease (GOLD) guidelines.\[13\] 3. Diagnosis of COPD exacerbation at admission, according to GOLD guidelines.\[13\] 4. Arterial…
Contacts

Francesco Salton, MD

00390403994667

francesco.salton@gmail.com

CONTACT

Msrco Confalonieri, MD

00390403994667

mconfalonieri@units.it

CONTACT